Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel
Date issued
2015Journal title
Asia-Pacific Journal of Clinical Oncology
Type of content
Publicación de congreso